Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
Day One Biopharmaceuticals (DAWN) Ownership Overview
17.59% Insiders
22.04% Mutual Funds
39.50% Other Institutional Investors
11.04% ETFs
9.83% Public Companies and Individual Investors
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 72.58% of the company’s stock is owned by Institutional Investors, 17.59% is owned by Insiders, and 9.83% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 21, 2024 | xxxxxxxxxxxxx | $131800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $16200 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $1690311 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2182391 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $23478668 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,929,322 | Insider | 12.76% | 80,808,263 | |
| 5,755,577 | Institution | 5.68% | 35,972,356 | |
| 5,543,076 | Institution | 5.47% | 34,644,225 | |
| 4,865,078 | Institution | 4.80% | 30,406,738 | |
| 3,103,448 | Institution | 3.06% | 19,396,550 | |
| 3,093,392 | Institution | 3.05% | 19,333,700 | |
| 2,960,740 | Institution | 2.92% | 18,504,625 | |
| 2,680,427 | Institution | 2.64% | 16,752,669 | |
| 2,558,563 | Institution | 2.52% | 15,991,019 | |
| 2,247,263 | Institution | 2.22% | 14,045,394 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,865,078 | Institution | 4.80% | 30,406,738 | |
| 3,093,392 | Institution | 3.05% | 19,333,700 | |
| 2,247,263 | Institution | 2.22% | 14,045,394 | |
| 1,812,632 | Institution | 1.79% | 11,328,950 | |
| 1,491,610 | Institution | 1.47% | 9,322,563 | |
| 1,395,300 | Institution | 1.38% | 8,720,625 | |
| 1,372,775 | Institution | 1.35% | 8,579,844 | |
| 1,144,703 | Institution | 1.13% | 7,154,394 | |
| 936,000 | Institution | 0.92% | 5,850,000 | |
| 560,163 | Institution | 0.55% | 3,501,019 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,401,280 | Institution | 2.37% | 18,681,958 | |
| 1,422,124 | Institution | 1.40% | 8,760,284 | |
| 1,367,670 | Institution | 1.35% | 8,547,938 | |
| 1,063,823 | Institution | 1.05% | 8,276,543 | |
| 960,242 | Institution | 0.95% | 12,166,266 | |
| 616,039 | Institution | 0.61% | 4,792,783 | |
| 464,403 | Institution | 0.46% | 2,902,519 | |
| 427,266 | Institution | 0.42% | 2,670,413 | |
| 323,422 | Institution | 0.32% | 1,992,280 | |
| 274,800 | Institution | 0.27% | 2,137,944 |
FAQ
Who Owns Day One Biopharmaceuticals (DAWN)?
According to the latest TipRanks data, approximately 39.50% of the company's stock is held by institutional investors, 17.59% is held by insiders, and 9.83% is held by retail investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.50% of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.83% of Day One Biopharmaceuticals (DAWN) stock is held by retail investors.
Who owns the most shares of Day One Biopharmaceuticals (DAWN)?
AI Day1 LLC owns the most shares of Day One Biopharmaceuticals (DAWN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.